Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Williams

Showing results (731-740 of 891) with videos related to

Pageof 90
Sort By:
Toxicology and Applied Pharmacology|April 11, 2013
Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implicationsMitchell R McGill, Margitta Lebofsky, Hye-Ryun K Norris, et al.
Targeted Oncology|May 27, 2014
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancerFiona Day, Andrea Muranyi, Shalini Singh, et al.
Journal of Vascular Surgery|April 11, 2020
Surgical management of pediatric renin-mediated hypertension secondary to renal artery occlusive disease and abdominal aortic coarctationDawn M Coleman, Jonathan L Eliason, Robert Beaulieu, et al.
Frontiers in Toxicology|March 26, 2024
Optimizing androgen receptor prioritization using high-throughput assay-based activity modelsRonnie Joe Bever, Stephen W Edwards, Todor Antonijevic, et al.
Atherosclerosis|June 20, 2018
Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control studyNorma C Serrano, Elizabeth Guio-Mahecha, Doris Cristina Quintero-Lesmes, et al.
Sexually Transmitted Infections|November 14, 2020
Improved sensitivity from pooled urine, pharyngeal and rectal specimens when using a molecular assay for the detection of chlamydia and gonorrhoea near point of careJudith Ann Dean, Sara Fiona Elizabeth Bell, Luke Coffey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiencySusannah I Thornhill, Axel Schambach, Steven J Howe, et al.
Biofouling|June 19, 2012
Poly(dimethyl siloxane) (PDMS) network blends of amphiphilic acrylic copolymers with poly(ethylene glycol)-fluoroalkyl side chains for fouling-release coatings. II. Laboratory assays and field immersion trialsElisa Martinelli, Mahesh K Sarvothaman, Giancarlo Galli, et al.
Frontiers in Toxicology|May 2, 2024
Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity modelsMark D Nelms, Todor Antonijevic, Caroline Ring, et al.
JAMA Dermatology|April 9, 2020
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical TrialAndrew Blauvelt, Craig L Leonardi, Melinda Gooderham, et al.
Pageof 90

Showing results (731-740 of 891) with videos related to

Sort By:
Pageof 90
Toxicology and Applied Pharmacology|April 11, 2013
Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implicationsMitchell R McGill, Margitta Lebofsky, Hye-Ryun K Norris, et al.
Targeted Oncology|May 27, 2014
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancerFiona Day, Andrea Muranyi, Shalini Singh, et al.
Journal of Vascular Surgery|April 11, 2020
Surgical management of pediatric renin-mediated hypertension secondary to renal artery occlusive disease and abdominal aortic coarctationDawn M Coleman, Jonathan L Eliason, Robert Beaulieu, et al.
Frontiers in Toxicology|March 26, 2024
Optimizing androgen receptor prioritization using high-throughput assay-based activity modelsRonnie Joe Bever, Stephen W Edwards, Todor Antonijevic, et al.
Atherosclerosis|June 20, 2018
Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control studyNorma C Serrano, Elizabeth Guio-Mahecha, Doris Cristina Quintero-Lesmes, et al.
Sexually Transmitted Infections|November 14, 2020
Improved sensitivity from pooled urine, pharyngeal and rectal specimens when using a molecular assay for the detection of chlamydia and gonorrhoea near point of careJudith Ann Dean, Sara Fiona Elizabeth Bell, Luke Coffey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiencySusannah I Thornhill, Axel Schambach, Steven J Howe, et al.
Biofouling|June 19, 2012
Poly(dimethyl siloxane) (PDMS) network blends of amphiphilic acrylic copolymers with poly(ethylene glycol)-fluoroalkyl side chains for fouling-release coatings. II. Laboratory assays and field immersion trialsElisa Martinelli, Mahesh K Sarvothaman, Giancarlo Galli, et al.
Frontiers in Toxicology|May 2, 2024
Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity modelsMark D Nelms, Todor Antonijevic, Caroline Ring, et al.
JAMA Dermatology|April 9, 2020
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical TrialAndrew Blauvelt, Craig L Leonardi, Melinda Gooderham, et al.
Pageof 90